PATENT CLAIM ANALYSIS

Application Number: 16007671
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "017500"]

Abstract:
The present invention pertains to novel uses of endomorphine-1 peptide, analogs, and salts thereof for therapy of children, patients currently suffering from drug addiction, patients prone to opioid addiction, and patients with chemo-induced pain.

Claim (Index 1):
A method for treating pain, inflammation, schizophrenia, coronary artery disease, seizure, and/or diarrhea, comprising administering, to a subject in need of such treatment, an effective amount of an isolated peptide or salt thereof, wherein the peptide has a general formula: Tyr-X 1 -X 2 -X 3 ,\n wherein X 1  is Pro, D-Lys or D-Orn, X 2  is Trp, Phe or N-alkyl-Phe, wherein alkyl contains 1 to about 6 carbon atoms, and X 3  is Phe, Phe-NH 2 , D-Phe, D-Phe-NH 2  or p-Y-Phe, wherein Y is NO 2 , F, Cl or Br; wherein the subject is a child, is prone to opioid addiction, and/or has chemotherapy-induced pain.

Metadata:
- Claim Count in Document: 45.0
- Percentile: 94.0
- Lexical Diversity: 1.33333
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15439813', '13477423', '14354092', '13003761', '14622660']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.708582214043345
- 35 USC 102 Novelty (BERT): 0.4918113587178409
- Combined Prediction Score: 0.6869051285107945
- Mean Citation Score: 209.60784400000003
- Max Citation Score: 217.47653
- Similarity Product: 152.66064756255986

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test